> top > docs > PMC:7558914 > spans > 30983-32335 > annotations

PMC:7558914 / 30983-32335 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
878 588-602 Gene denotes LR1 NR NR 1 Gene:2902
879 668-682 Gene denotes LR1 NR NR 1 Gene:2902
880 703-717 Gene denotes LR2 NR NR 1 Gene:2902
881 738-752 Gene denotes LR1 NR NR 1 Gene:2902
882 430-435 Gene denotes NR 1 Gene:2902
883 127-146 Disease denotes Respiratory Illness MESH:D012140
884 180-189 Disease denotes Pneumonia MESH:D011014
885 200-209 Disease denotes Pneumonia MESH:D011014
886 218-227 Disease denotes Pneumonia MESH:D011014
887 275-288 CellLine denotes NR NR NR H2 CVCL:6690
889 43-67 Disease denotes coronavirus disease 2019 MESH:C000657245
892 1205-1224 Chemical denotes lopinavir/ritonavir MESH:C558899
893 1271-1290 Chemical denotes lopinavir/ritonavir MESH:C558899

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T55 127-146 Phenotype denotes Respiratory Illness http://purl.obolibrary.org/obo/HP_0002086
T56 180-189 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090
T57 200-209 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090
T58 218-227 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T208 0-100 Sentence denotes Table 2 Antiviral treatment protocols for coronavirus disease 2019 according to clinical condition.
T209 101-227 Sentence denotes Antiviral Treatment Mild Respiratory Illness with Clinical Risk Factors Mild Pneumonia Moderate Pneumonia Severe Pneumonia
T210 228-259 Sentence denotes No 2 (13.3%) 1 (6.7%) NR NR
T211 260-285 Sentence denotes H1 5 (33.3%) NR NR NR
T212 286-310 Sentence denotes H2 1 (6.7%) NR NR NR
T213 311-336 Sentence denotes LR1 1 (6.7%) NR NR NR
T214 337-379 Sentence denotes H1 + A 3 (20.0%) 4 (26.6%) 1 (6.7%) NR
T215 380-421 Sentence denotes H2 + A 1 (6.7%) 2 (13.3%) 1 (6.7%) NR
T216 422-463 Sentence denotes H3 + A NR 1 (6.7%) 2 (13.3%) 1 (6.7%)
T217 464-498 Sentence denotes H4 + A NR NR 1 (6.7%) 1 (6.7%)
T218 499-537 Sentence denotes H1 + LR1 2 (13.3%) 3 (20.0%) NR NR
T219 538-582 Sentence denotes H1 + LR2 NR 1 (6.7%) 5 (33.3%) 3 (20.0%)
T220 583-613 Sentence denotes H3 + LR1 NR NR 1 (6.7%) NR
T221 614-658 Sentence denotes H3 + LR2 NR 3 (20.0%) 1 (6.7%) 4 (26.6%)
T222 659-693 Sentence denotes H1 + A + LR1 NR NR 1 (6.7%) NR
T223 694-728 Sentence denotes H1 + A + LR2 NR NR 1 (6.7%) NR
T224 729-763 Sentence denotes H3 + A + LR1 NR NR 1 (6.7%) NR
T225 764-799 Sentence denotes H3 + A + LR2 NR NR NR 6 (40.0%)
T226 800-1138 Sentence denotes H1: hydroxychloroquine 400 mg/12 h (day 1) + 200 mg/12 h (day 2 to 5) (regimen 1); H2: hydroxychloroquine 400 mg/12 h (day 1) + 200 mg/8 h (day 2 to 5) (regimen 2); H3: hydroxychloroquine 400 mg/12 h (day 1) + 200 mg/12 h (day 2 to 7–10) (regimen 3); H4: hydroxychloroquine 400 mg/12 h (day 1) + 200 mg/8 h (day 2 to 7–10) (regimen 4); A:
T227 1139-1352 Sentence denotes Azithromycin 500 mg/24 h (day 1) + 250 mg/24 h (day 2 to 5); LR1: lopinavir/ritonavir 200/50 mg/12 h (day 1 to 5) (regimen 1); LR2: lopinavir/ritonavir 200/50 mg/12 h (day 1 to 7–10) (regimen 2); NR: not reported.